Pharma Focus Asia
KP - Sustainable Packaging Solutions

Umoja Biopharma Plans to Construct New Manufacturing Facility in Colourado, USA

Introduction:

Umoja Biopharma plans for the construction of a new state-of-the-art laboratory and innovative manufacturing facility in Colourado, USA.

Features:

The facility is designed to accelerate therapeutic candidate development. 

The first phase covers 77,000 square feet, housing cutting-edge labs, offices, and manufacturing areas tailored for lentiviral vector production. 

This space is designed with the flexibility to expand to 146,000 square feet, aligning seamlessly with anticipated future supply requirements.

The opening of this facility will support the development and commercialisation of gene therapies that can scale effectively by creating a significant and meaningful impact on the lives of patients globally.

This facility is set to drive in-house tech development, guarantee top-notch quality for clinical trials, and establish a robust, adaptable supply chain foundation.

The laboratory & innovative manufacturing building is is projected for the first quarter of 2024.

Specifications:

Name  Umoja Biopharma
Type    New Construction
Year     2024
 

Latest Issue
Get instant
access to our latest e-book
Standard BioTools™MFA + MMA 2024Gibco Adherent Kidney Media PanelTFS - ODW - The Technology Debate: Single-Use vs. Stainless SteelAsia Healthcare Week 2024CPHI Korea 2024CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 20244th Middle East Pharmacoeconomics and Drug Policy Summit 2024Digital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals Conference
Searching for an end-to-end patient tech solution?